جستجوی استاد راهنمای دانشگاهی

Zelalem Negeri is an Assistant Professor in the Department of Statistics and Actuarial Science at the University of Waterloo, affiliated with the Faculty of Mathematics. His work focuses on statistical methods for diagnostic test accuracy, depression screening tools, and meta-analytic techniques. He collaborates with groups like DEPRESSD (Depression Screening Data) to improve mental health assessment methodologies. Research interests include robust meta-analysis models for accommodating outliers, optimal cutoff determination for screening tools (e.g., PHQ-9, EPDS), and evaluating diagnostic accuracy across diverse populations. His studies often use individual participant data (IPD) to enhance precision in estimating depression prevalence and screening tool performance. Recent work emphasizes validating shortened screening tools (e.g., EPDS-Dep-5) and comparing depression assessment methods across modes (e.g., self-administered vs. clinician-administered). He also investigates pandemic-related mental health impacts in populations with systemic sclerosis and explores statistical methods to mitigate biases in data-driven cutoff selection. No scientific awards are explicitly mentioned. His contributions span collaborations with interdisciplinary teams, including the Scleroderma Patient-centered Intervention Network (SPIN), and involve developing robust statistical frameworks to address variability in diagnostic studies.

• Biostatistics
• Meta-Analysis
• Diagnostic Test Accuracy
• +۳ مورد دیگر

Dr. Bei Jiang is an Associate Professor in the Department of Mathematical and Statistical Sciences at the University of Alberta , Canada. She holds the Canada CIFAR AI Chair and is affiliated with the Alberta Machine Intelligence Institute (Amii) . Her academic journey includes a PhD in Biostatistics (2014) from the University of Michigan, MS (2008) and BS (2004) from the University of Alberta and Beijing University of Technology, respectively. Current Positions : 2021–Present (Associate Professor), 2022–Present (CIFAR AI Chair) Past Appointments : Assistant Professor (2015–2021), Postdoctoral Fellow at Columbia University (2014–2015), Research Assistant at University of Michigan (2009–2013) Research Interests : Dr. Jiang specializes in methods for joint modeling of longitudinal and health outcome data , Bayesian hierarchical modeling , functional and imaging data analysis , and statistical machine learning . Her work integrates kernel machine regression , differential privacy , and synthetic data generation to address challenges in heterogeneous health data and neuroimaging. Scientific Awards : Highlights include the 2015 SAMSI New Research Fellow , multiple Rackham Conference Travel Awards (2013, 2012), and prestigious NSERC scholarships (2009–2012). She has also received the J Gordin Kaplan Graduate Award (2008) and Statistical Society of Canada Travel Award (2008). Grants : $375,000 (CIFAR AI Chairs, 2022–2027), $480,000 (MITACS Accelerate, 2022–2025), and $210,000 (Canadian Statistical Sciences Institute, 2022–2025) Students and Postdocs : She mentors numerous PhD , MSc , and Postdoctoral Fellows , including Junxi Zhang (2023–Present), Enze Shi (2022–Present), and former advisees like Wenxing Guo (now Lecturer at University of Essex) and Yafei Wang (Assistant Professor at University of Alberta).

• Biostatistics
• Functional Data Analysis
• Statistical Machine Learning
• +۶ مورد دیگر

Eduardo N. Chini, M.D., Ph.D., is a Professor at Mayo Clinic with primary and joint appointments in the Department of Anesthesiology and Perioperative Medicine and the Department of Cancer Biology. He is based in Rochester, Minnesota, and leads a research program focused on NAD metabolism, aging, and their roles in diseases such as cancer, obesity, and kidney disease. Education: BS in Biology, Centro Educacional de Niteroi-RJ MD, Universidade do Rio de Janeiro PhD in Biological Chemistry, Universidade do Rio de Janeiro Fellow, Department of Physiology and Biophysics, Mayo Clinic Resident in Anesthesiology, Mayo Clinic College of Medicine Research Interests: Eduardo N. Chini's research investigates the central role of nicotinamide adenine dinucleotide (NAD) in cellular metabolism, aging, and disease. His lab has made foundational discoveries in NAD catabolism, identifying CD38 as the primary enzyme regulating NAD levels in mammals. His work explores SIRT1 regulation via CD38 and DBC1, NAD metabolism in cancer, and its implications in polycystic kidney disease. He is particularly interested in how NAD signaling influences aging, metabolic syndrome, and organ dysfunction. Recent Research Trends: His recent publications (2023–2025) reveal a strong focus on the role of CD38 in aging, immune function, and tissue metabolism. Key themes include NAD+ depletion triggering inflammatory responses, CD38 inhibition as a therapeutic strategy for cardiotoxicity and metabolic aging, and the interplay between senescence, stem cell function, and mitochondrial health. His work increasingly integrates translational models with molecular mechanisms in aging and cancer. Scientific Awards: Florida Investigator of the Year, Mayo Clinic (2024) Glenn/AFAR Breakthroughs in Gerontology Award (2007) Edward C. Kendall Award, Mayo Clinic Alumni Association (2002) Directors Award for Aging Research, Kogod Center on Aging (2018) Distinguished Scientist Seminar Series, Georgetown Medical School (2022) Grants and Leadership: Dr. Chini is a co-Principal Investigator on multiple NIH-funded grants, including projects on CD38 in scleroderma, CLL, and male reproductive aging. He is Co-Director of the Mayo Clinic Mitochondrial Care Center and Associate Director of the Robert and Arlene Kogod Center on Aging. He has served on numerous national review panels and advisory councils, including the NIH Hepatobiliary Pathophysiology Study Section and AFAR's National Scientific Advisory Council. Labs and Teams: Dr. Chini leads a research laboratory at Mayo Clinic focused on NAD metabolism and aging. His team collaborates extensively with experts in cancer biology, mitochondrial medicine, and aging research. He is affiliated with the Mayo Clinic Comprehensive Cancer Center, the Kogod Center on Aging, and the Robert M. and Billie Kelley Pirnie Translational PKD Center.

• Metabolism
• NAD Metabolism
• Aging
• +۱۱ مورد دیگر

Agustín España Alonso is the Director of the Department of Dermatology at the University of Navarra Clinic, where he specializes in Medical-Surgical and Venereological Dermatology. He is a Professor at the Faculty of Medicine of the University of Navarra since 2014 and was previously Vice Dean of the Faculty in 2003. His clinical focus is on autoimmune blistering diseases, and he has contributed extensively to research and education in dermatology. Graduated in Medicine from the Autonomous University of Madrid (1984) Specialized in Dermatology at Ramón y Cajal Hospital (1986-1989) PhD in Medicine from the Autonomous University of Madrid (1990) Clinical Research Fellow in Immunodermatology at the Medical College of Wisconsin, USA (1994-1995) His research interests include: Autoimmune blistering diseases (e.g., pemphigus vulgaris, bullous pemphigoid) Atopic dermatitis Connective tissue diseases (e.g., lupus erythematosus, scleroderma) Hyperhidrosis Inflammatory skin diseases of immunological origin He has led 6 research projects as Principal Investigator, participated in 2 as collaborator, and developed 6 research protocols. He has authored 80 international journal articles, edited 5 books, and written 33 book chapters, while directing 6 doctoral theses. He is accredited as a University Professor by Spain’s Ministry of Education. Member of the Spanish Academy of Dermatology and Syphiliography (since 1998) Member of the American Academy of Dermatology (since 2002) President of the Basque-Navarre-Aragonese-Riojana Section of the Spanish Academy of Dermatology and Venereology (2003–2007) Member of the Editorial Committee of PIEL Journal and Editorial Board of Actas Dermo-Sifiliográficas Journal

• Immunodermatology
• Autoimmune Disorders
• Inflammatory Skin Diseases
• +۳ مورد دیگر

Daphna Harel (she/her) serves as Associate Professor of Applied Statistics and Director of the A3SR MS Program within the Department of Applied Statistics, Social Science, and Humanities at New York University's Steinhardt School of Culture, Education, and Human Development. She holds leadership roles including PI of the NYU QUEER data lab and membership on the steering committee for the DEPRESSD project. Education: PhD in Mathematics and Statistics from McGill University Harel's research focuses on measurement challenges in survey methodology, particularly for self-reported questionnaires in health and social sciences. Her work bridges theoretical statistics with practical applications in LGBTQIA+ data collection, differential item functioning, and patient-reported outcomes. She develops methodological frameworks for polytomous Item Response Theory and creates guidelines for statistical analysis of complex survey data. Her recent work emphasizes improving statistical practice for LGBTQIA+ populations and advancing queer data collection methods. Her publication portfolio demonstrates consistent focus on measurement validity across diverse health contexts, with recent work expanding into LGBTQIA+ data science. Her research shows increasing emphasis on methodological innovations for gender and sexuality measurement, with multiple publications presented at major conferences including AAPOR 2024 and LGBTQ+ Health Conference 2024. Research Leadership: PI of NYU QUEER data lab (founded Fall 2022) Steering committee member for DEPRESSD project Collaborator with Scleroderma Patient-centered Intervention Network Recipient of NIH R21 funding and NYU intramural grants Harel mentors a diverse team of graduate students through the Applied Statistics for Social Science Research program, focusing on inclusive research methods for marginalized populations. Her grant portfolio includes investigations into transgender voice training, LGBTQIA+ survey methodology, and healthcare access for gender-affirming services. Laboratory Leadership: As founder and PI of the NYU QUEER data lab, Harel leads research projects examining survey question design for gender/sexuality measurement, content moderation effects on hate speech, and accessibility of transgender voice training. The lab operates through collaboration between NYU Steinhardt and the NYU BITS lab, with research assistants drawn from the Applied Statistics MS program.

• Survey Methodology
• Measurement Theory
• LGBTQIA+ Data Analysis
• +۶ مورد دیگر

Evelyn Sutton is a Professor in the Division of Rheumatology within the Department of Medicine at Dalhousie University's Faculty of Medicine. She concurrently serves as director of the Arthritis Centre of Nova Scotia and assistant dean of admissions for Dalhousie Medical School. Her primary research focuses include: Medical Education: Recognized for exceptional teaching with multiple unspecified awards, she maintains a dedicated focus on curriculum development and pedagogical innovation in medical training. Scleroderma Research: As an autoimmune disease specialist, she investigates clinical outcomes improvement strategies, particularly through non-invasive diagnostic approaches for pulmonary arterial hypertension in scleroderma patients. Dr. Sutton actively contributes to the Canadian Scleroderma Research Group, participating in national and international collaborative studies aimed at advancing scleroderma treatment protocols. While her academic position implies student mentorship responsibilities, the source material provides no specific details regarding advisees or grant funding. Her clinical practice has transitioned to non-referral status as indicated in the departmental profile.

• Medical Education
• Rheumatology
• Scleroderma
• +۲ مورد دیگر

Joanne Sahhar is an Adjunct Clinical Associate Professor in the Faculty of Medicine at Monash University and a practicing rheumatologist at Monash Health. She serves as Head of the Scleroderma Clinic within the Centre for Inflammatory Disease, where she leads clinical and research initiatives focused on systemic sclerosis and related autoimmune conditions. Her research interests center on systemic sclerosis , interstitial lung disease , pulmonary hypertension , biomarkers , and Raynaud phenomenon . She investigates the epidemiology, clinical outcomes, and environmental influences on scleroderma, with a strong emphasis on improving early diagnosis and treatment strategies. Her recent publications demonstrate a consistent focus on clinical outcomes in scleroderma, including the impact of the COVID-19 pandemic on care access, risk assessment for pulmonary hypertension, and outcomes of stem cell transplantation. These works reflect a multidisciplinary approach integrating rheumatology, cardiology, and environmental health. ARA President’s Prize for Excellence in Collaborative Research (2018) Paper selected for Best of ICB/CTI Workshop at 2019 ASI Annual Scientific Meeting Dr. Sahhar actively supervises PhD students and collaborates widely across national and international research networks. She holds leadership roles as Chair of the Australian Working Group for Autologous Stem Cell Transplantation in Scleroderma and as a member of the executive and scientific committees of the Australian Scleroderma Interest Group. She also serves as a reviewer for journals including Arthritis and Rheumatology , J Rheumatology , and Rheumatology International . She is actively involved in clinical research and mentoring, contributing significantly to the advancement of knowledge in scleroderma and autoimmune rheumatic diseases.

• Systemic Sclerosis
• Scleroderma
• Interstitial Lung Disease
• +۷ مورد دیگر

Alisa N. Femia, MD is an Associate Professor in the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine. She serves as Director of Faculty Development and Director of Inpatient Dermatology at NYU Langone. Her clinical expertise focuses on autoimmune cutaneous conditions, including dermatomyositis, cutaneous lupus, and systemic sclerosis. Dr. Femia completed a dermatology-rheumatology fellowship at Brigham and Women’s Hospital (Harvard Medical School), enhancing her capacity to manage complex multisystem autoimmune diseases. She is actively involved in medical education, having received multiple teaching awards, and participates in national medical societies. Her research investigates autoimmune skin disorders, with publications in high-impact journals like Lancet and JAMA Dermatology . She leads clinical trials exploring novel therapies for inflammatory myopathies and has contributed to over 110 publications. Dr. Femia provides care at NYU Langone Dermatologic Associates, emphasizing holistic patient care that integrates medical and dermatologic expertise.

• Autoimmune Connective Tissue Diseases
• Dermatomyositis
• Cutaneous Lupus Erythematosus
• +۴ مورد دیگر

Mary Beth Scholand, MD is an Associate Professor in the Department of Internal Medicine at the University of Utah School of Medicine, specializing in Pulmonary Medicine. She serves as Director of the Interstitial Lung Disease Clinic at University of Utah Hospital and provides clinical care across multiple University of Utah Health locations including Farmington, South Jordan, Sugar House, and University Hospital. Her educational background includes: B.S. from Northwestern University M.D. from Washington University Internal Medicine Internship and Residency at Barnes Hospital Pulmonary Medicine Fellowship at University of Utah School of Medicine Dr. Scholand's research centers on interstitial lung diseases, with primary focus on idiopathic pulmonary fibrosis (IPF), sarcoidosis, and autoimmune lung diseases. She investigates genetic and phenotypic factors in chronic obstructive pulmonary disease (COPD) and interstitial lung diseases (ILD), while leading clinical trials targeting IPF cures and novel monitoring programs. Her work bridges pulmonary medicine, rheumatology, and oncology through translational research. Analysis of her 15 most recent publications reveals dominant themes in ILD therapeutics, clinical guideline development, and international registry studies. Key trends include antifibrotic drug trials (bexotegrast, pirfenidone), multidisciplinary management frameworks for autoimmune-related ILD, and pandemic-era adaptations in sarcoidosis care. Her research consistently addresses diagnostic challenges, therapeutic innovations, and patient-centered outcomes across pulmonary subspecialties. As Director of the Interstitial Lung Disease Clinic, Dr. Scholand leads a multidisciplinary team managing complex cases through integrated diagnostics and personalized treatment plans. Her clinical trials portfolio demonstrates active grant funding for therapeutic innovations in IPF and ILD, while her guideline contributions to ACR/CHEST and ATS reflect leadership in standardizing global care practices. Patient testimonials consistently highlight her expertise, thoroughness, and compassionate bedside manner, with a 4.9/5 rating from over 457 reviews.

• Interstitial Lung Disease
• Idiopathic Pulmonary Fibrosis
• Sarcoidosis
• +۵ مورد دیگر

Susan W. Law, DO, MPH is a Clinical Associate Professor of Neurology at SUNY Downstate Health Sciences University and Director of the Stroke Center at Kings County Hospital, specializing in cerebrovascular diseases within urban minority populations. Her academic credentials include: Doctor of Osteopathic Medicine (DO) from New York College of Osteopathic Medicine Neurology Residency at SUNY Downstate Health Sciences University Cerebrovascular Diseases Fellowship at SUNY Downstate Health Sciences University Master of Public Health in Epidemiology from SUNY Downstate School of Public Health Dr. Law's research centers on stroke neuroimaging, clinical trials (notably ARCADIA), and hospital quality improvement targeting medication adherence and readmission rates. She investigates post-stroke depression, fatigue, and disability with emphasis on health disparities in minority communities, leveraging epidemiological methods and urban hospital data. Her publication analysis reveals consistent focus on stroke outcomes in underserved populations, rare cerebrovascular etiologies, and emergency stroke recognition systems. Methodological diversity includes randomized trials, cohort studies, and case series examining pharmacological interventions and social determinants of stroke recovery. As a research leader, she served as Site Principal Investigator for ATACH-2 and SHINE clinical trials and Site Co-Investigator for ARTSS-2. Her mentorship of medical trainees is evidenced by multiple mentored research abstracts at institutional and national conferences. Directing Kings County Hospital's Stroke Center, she oversees acute intervention protocols, telestroke initiatives, and quality improvement programs addressing systemic barriers in urban stroke care delivery.

• Stroke
• Cerebrovascular Diseases
• Neuroimaging
• +۲ مورد دیگر

Marissa A. Blum, MD, MS is a Clinical Professor of Medicine at the Lewis Katz School of Medicine at Temple University, specializing in Rheumatology. She practices at Temple Rheumatology with offices located at both the Main Campus (3401 N. Broad St., Outpatient Building, 4th Floor, Philadelphia) and Jeanes Campus (7500 Central Avenue, Philadelphia). Education: MD from The Johns Hopkins University School of Medicine, Baltimore, MD; MSHPR (Masters in Health Policy Research) from University of Pennsylvania, Philadelphia, PA Training: Rheumatology Fellowship at The Hospital of the University of Pennsylvania; Internal Medicine Residency at The Johns Hopkins Hospital Certifications: American Board of Internal Medicine - Internal Medicine and Rheumatology Memberships: American College of Rheumatology, American College of Physicians Dr. Blum's research focuses on healthcare disparities, health economics, outcomes-based research, and medical decision making in rheumatology. Her clinical expertise spans rheumatoid arthritis, scleroderma, systemic lupus erythematosus, vasculitis, gout, cryoglobulins, osteoarthritis, Still's Disease, and women's health. She has maintained an impressive patient satisfaction rating of 4.8 out of 5 based on 199 patient reviews, with patients consistently praising her clear explanations, courtesy, respect, and thorough discussion of treatment options. Her publication history demonstrates a strong research trajectory with emphasis on healthcare disparities in joint replacement, medication adherence for rheumatoid arthritis, and biologic therapies. The majority of her publications (2004-2013) reflect her dual expertise in rheumatology and health policy research, with several focusing on racial/ethnic disparities in treatment and outcomes. Phi Beta Kappa, Villanova University Harold Lamport Research Award, Johns Hopkins University Most Aequinimitas Intern Award, Johns Hopkins University Top Doctors, Rheumatology, Philadelphia magazine (2017-2020, 2024-2025) As a highly rated physician with nearly 200 patient reviews, Dr. Blum maintains active clinical practice while contributing to rheumatology research. Her work bridges clinical care with health policy analysis, particularly examining how economic factors and demographic variables affect treatment access and outcomes for rheumatology patients.

• Rheumatology
• Healthcare Disparities
• Health Economics
• +۸ مورد دیگر

Elizabeth Bailey is a Clinical Associate Professor in the Department of Dermatology at Stanford University School of Medicine. She holds multiple administrative roles, including Program Director for the Stanford Dermatology Residency Program , Associate Clinic Chief of Medical Dermatology at Stanford Healthcare, and Director of Global Health Dermatology . Her work focuses on improving medical education, patient communication, and global health initiatives in dermatology. Harvard University, AB, magna cum laude (2006) Harvard School of Public Health, MPH (2011) Columbia University College of Physicians and Surgeons, MD (2011) Brigham and Women’s Hospital, Internal Medicine Internship (2012) Stanford University, Dermatology Residency (2015) and Dermatopathology Fellowship (2016) Dr. Bailey's research emphasizes medical education innovation , particularly in integrating sexual and gender minority and skin of color topics into residency training. She explores communication skills development and uses art-based methods for professional training. Her recent publications address skin cancer surveillance by non-medical professionals, cultural humility in patient care, and machine learning applications for skin tone representation in educational materials. Key trends in her publications include: Expanding skin cancer detection networks through community partnerships Addressing racial disparities in dermatological education Optimizing clinical workflows via digital tools Advancing global health equity in dermatology Professional affiliations: Fellow, American Academy of Dermatology Fellow, Center for Innovation in Global Health Member, San Francisco Dermatological Society Member, Women's Dermatologic Society

• Medical Education
• Global Health
• Skin Cancer Detection and Prevention
• +۵ مورد دیگر

Dr. Ira Kurtz is a Professor of Medicine at the University of California, Los Angeles (UCLA), and Chief of Nephrology. He is also a Member of the Brain Research Institute. His research focuses on renal physiology, acid-base homeostasis, and molecular transport mechanisms, particularly within the SLC4 transporter family. His work spans structural biology, molecular dynamics, and clinical nephrology. His scientific contributions include structural characterization of SLC4 transporters using cryo-EM and molecular dynamics simulations, revealing key insights into ion translocation pathways and conformational dynamics. He has extensively studied the molecular basis of proximal renal tubular acidosis and electrolyte disorders, with particular emphasis on NBCe1 transporter function and regulation. Dr. Kurtz's publications demonstrate expertise in renal acid-base physiology, membrane transporter characterization, and clinical applications. His work connects fundamental molecular mechanisms with human diseases, including corneal endothelial dystrophies, thrombotic microangiopathy from anti-VEGF treatments, and genetic disorders affecting ion transport. His research methodology integrates computational biology, structural biology, and translational medicine approaches. He has developed novel quantitative models for acid-base analysis and electrolyte disorders, challenging established paradigms like the Stewart approach through critical evaluation of bicarbonate-centered models.

• Renal Physiology
• Acid-Base Homeostasis
• Molecular Transport Mechanisms
• +۳ مورد دیگر

Yvonne C Lee, MD, MMSc is the Helen Myers McLoraine Professor of Rheumatology in the Department of Medicine at Northwestern University Feinberg School of Medicine. She holds multiple institutional affiliations including the Center for Circadian and Sleep Medicine, Center for Human Immunobiology, Institute for Public Health and Medicine (IPHAM), and Northwestern University Clinical and Translational Sciences Institute (NUCATS). Her clinical practice is based at Northwestern Memorial Hospital and Shirley Ryan AbilityLab. Dr. Lee's research focuses on understanding pain mechanisms in rheumatoid arthritis and other systemic rheumatic conditions, with emphasis on pain centralization and non-inflammatory pain pathways. Her work integrates clinical trials, quantitative sensory testing, neuroimaging, and patient-reported outcomes to develop effective pain management strategies. She leads multiple active clinical trials including CPIRA-2, IMPACT-Pain-RA, PROMOTER, and CATCH-US investigating pain centralization biomarkers and treatment responses in rheumatoid arthritis. Analysis of Dr. Lee's recent publications reveals a consistent research trajectory centered on pain centralization in rheumatic diseases, particularly examining the relationship between sleep disturbance, quantitative sensory testing abnormalities, and patient-reported pain outcomes. Her work increasingly incorporates multi-modal pain assessment and biomarker discovery to address unmet needs in chronic pain management for rheumatoid arthritis patients. Department of Medicine Teaching Award, Northwestern University Feinberg School of Medicine (2020) Department of Medicine Teaching Award, Northwestern University Feinberg School of Medicine (2019) Innovation Discovery, Partners Healthcare (2016) Chair's Research Award, Brigham & Women's Hospital (2014) Dr. Lee serves as Associate Editor for Arthritis and Rheumatology and has held editorial positions at Arthritis Care & Research and Pain Medicine. She leads multiple NIH-funded clinical trials with significant grant support, focusing on pain mechanisms in rheumatoid arthritis. Her mentorship extends through her role in the American College of Rheumatology Research and Publications Subcommittee and Early Career Investigator Subcommittee. Dr. Lee directs research initiatives within the Center for Circadian and Sleep Medicine and Center for Human Immunobiology, collaborating with interdisciplinary teams to investigate the intersection of immune dysregulation, sleep disturbances, and pain processing in rheumatic diseases. Her laboratory work integrates clinical phenotyping with quantitative sensory testing and neuroimaging to characterize pain pathways.

• Rheumatoid Arthritis
• Pain Mechanisms
• Central Sensitization
• +۵ مورد دیگر

Associate Professor Suzanne Donnelly serves as Director of Clinical Education and Associate Dean for Programmes & Educational Innovation at University College Dublin's School of Medicine, while maintaining a part-time consultant rheumatology practice at Mater Misericordiae University Hospital specializing in systemic lupus erythematosus and pregnancy management in rheumatic conditions. Education: Medical degree from Trinity College, University of Dublin Specialty clinical training in Ireland and Oxford Her research integrates medical education with clinical practice, pioneering initiatives like the UCD Patient Educator Programme and Care in Medicine curriculum. She investigates empathy development in clinicians, clinical handover protocols, and evidence-based rheumatology care pathways through national collaborations with the Medical Council and National Clinical Effectiveness Committee. Scientific Awards: MD for research on empathy and care in medical education (2016) University Fellowship in Teaching and Academic Development (2014) Dr. Donnelly led Ireland's Medical Council report establishing the Safe Start initiative for new physicians and co-developed national clinical handover guidelines. She serves as external examiner for University of Dundee's medical program and contributes to key textbooks including Medicine At a Glance. She co-leads UCD's Care in Medicine curriculum with Professor Brendan Drumm, represents Ireland on EULAR's Standing Committee on Education, and maintains active roles with Arthritis Ireland, Raynaud’s and Scleroderma Ireland, and Lupus Group Ireland.

• Medical Education
• Rheumatology
• Clinical Handover
• +۳ مورد دیگر